Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis Journal Article


Authors: Ramchandani, D.; Berisa, M.; Tavarez, D. A.; Li, Z.; Miele, M.; Bai, Y.; Lee, S. B.; Ban, Y.; Dephoure, N.; Hendrickson, R. C.; Cloonan, S. M.; Gao, D.; Cross, J. R.; Vahdat, L. T.; Mittal, V.
Article Title: Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis
Abstract: Copper serves as a co-factor for a host of metalloenzymes that contribute to malignant progression. The orally bioavailable copper chelating agent tetrathiomolybdate (TM) has been associated with a significant survival benefit in high-risk triple negative breast cancer (TNBC) patients. Despite these promising data, the mechanisms by which copper depletion impacts metastasis are poorly understood and this remains a major barrier to advancing TM to a randomized phase II trial. Here, using two independent TNBC models, we report a discrete subpopulation of highly metastatic SOX2/OCT4+ cells within primary tumors that exhibit elevated intracellular copper levels and a marked sensitivity to TM. Global proteomic and metabolomic profiling identifies TM-mediated inactivation of Complex IV as the primary metabolic defect in the SOX2/OCT4+ cell population. We also identify AMPK/mTORC1 energy sensor as an important downstream pathway and show that AMPK inhibition rescues TM-mediated loss of invasion. Furthermore, loss of the mitochondria-specific copper chaperone, COX17, restricts copper deficiency to mitochondria and phenocopies TM-mediated alterations. These findings identify a copper-metabolism-metastasis axis with potential to enrich patient populations in next-generation therapeutic trials. © 2021, The Author(s).
Keywords: metabolism; protein; proteomics; tumor; mitochondrion; copper; chemical reaction; inhibition; subpopulation; chelating agent; detection method; cancer
Journal Title: Nature Communications
Volume: 12
ISSN: 2041-1723
Publisher: Nature Publishing Group  
Date Published: 2021-12-15
Start Page: 7311
Language: English
DOI: 10.1038/s41467-021-27559-z
PROVIDER: scopus
PMCID: PMC8674260
PUBMED: 34911956
DOI/URL:
Notes: Article -- Export Date: 3 January 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Justin Robert Cross
    111 Cross
  2. Linda T Vahdat
    43 Vahdat
  3. Matthew M Miele
    19 Miele
  4. Zhuoning Li
    19 Li
  5. Mirela Berisa
    6 Berisa